Potential impact of 5 years of ivermectin mass drug administration on malaria outcomes in high burden countries

INTRODUCTION: The global progress against malaria has slowed significantly since 2017. As the current malaria control tools seem insufficient to get the trend back on track, several clinical trials are investigating ivermectin mass drug administration (iMDA) as a potential additional vector control...

Descripción completa

Detalles Bibliográficos
Autores principales: Marathe, Achla, Shi, Ruoding, Mendez-Lopez, Ana, Hu, Zhihao, Lewis, Bryan, Rabinovich, Regina, Chaccour, Carlos J, Rist, Cassidy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587489/
https://www.ncbi.nlm.nih.gov/pubmed/34764146
http://dx.doi.org/10.1136/bmjgh-2021-006424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587489/
https://www.ncbi.nlm.nih.gov/pubmed/34764146
http://dx.doi.org/10.1136/bmjgh-2021-006424

Ejemplares similares